Health industries

Our client sought to strengthen how it monitors and responds to evolving regulatory requirements across its organisation. We were engaged to redesign end-to-end processes, governance, decision-making structures, and accountability models to enable more effective management of regulatory developments. AI was incorporated from the outset to support intelligent intake, signal prioritisation, and expert routing, while maintaining human oversight of critical decisions. This established a scalable, governed, and data-driven framework for managing regulatory change more effectively across the enterprise.

In preparation for a future advanced therapy launch, our client sought to define a customer service and distribution model that could meet highly specialised requirements while leveraging existing in-house capabilities. We supported a structured assessment across order-to-cash, customer service, transport, and manufacturing, complemented by an RFP involving 10 potential service providers. This enabled the client to benchmark internal and external options across cost, quality, experience, strategic fit, and operational requirements. We provided a clear recommendation on the preferred supply chain strategy, supported by a detailed three-year roadmap outlining the key phases, workstreams, and timelines required to build launch readiness.

As our client prepared to transition from clinical to commercial production, they needed to understand the impact on future logistics flows, capacity, and operating requirements. We developed a model based on sales and production plans to forecast logistics volumes and complexity across inbound and outbound flows. We then assessed alternative concepts for each flow segment against cost, capacity, complexity, and quality criteria. This provided a clear view of the preferred future logistics set-up, including storage locations and required capabilities to operate and manage the expanded network effectively.

Our client, a global leader in dialysis products and services, saw a major opportunity in India’s fast-growing dialysis market and needed to determine how best to serve it. We assessed the full range of strategic options for bloodline products, from local greenfield manufacturing and partnerships to alternative supply chain models. Combining market intelligence, location screening, business case modelling, government incentive analysis, and on-the-ground stakeholder engagement, we identified the most attractive path forward. This gave the client the confidence to shape a future-ready manufacturing and supply chain strategy for one of the world’s most dynamic healthcare markets.

Our client, a leading medical technology company, sought to strengthen its pricing approach across divisions and countries, address margin erosion, and establish a more consistent framework for profitable growth. We assessed existing pricing and profitability capabilities through stakeholder interviews and detailed analysis of customer and product dimensions, identifying priority improvement opportunities and defining a clear roadmap. We then developed a standardised price-setting framework with floor and target prices for each product and customer segment. This provided greater transparency on profitability, highlighted regions with pricing potential, and identified an annual EBIT improvement opportunity estimated to be worth millions.

Our client, a medical device company, sought to strengthen its market access and prepare for successful commercialisation in a complex healthcare environment. We developed an integrated strategy combining stakeholder mapping, value proposition development, care pathway analysis, and health technology assessment evidence planning. This provided a clear understanding of payer and healthcare professional needs, strengthened the product’s value narrative, and supported more effective engagement across the market access and commercialisation journey.

Our client, a mid-sized medical devices company, sought to strengthen its reward and compensation framework for key talent across Europe. We reviewed and benchmarked existing long-term incentive arrangements, assessed their tax efficiency, and designed a harmonised reward policy across the region. This provided a more consistent and competitive approach to remuneration, supporting the attraction and retention of critical R&D and commercial talent while optimising the tax and social security cost of compensation packages.

Our client, a health advocacy organisation, sought to raise awareness of sepsis among policymakers, healthcare professionals, and the wider public, while supporting the implementation of a national action plan. We were engaged to capture and amplify the key messages emerging from a major sepsis summit. Our role included producing a professionally designed event summary, developing an infographic, and creating a white paper based on an in-depth interview with a board member. This provided the client with a compelling suite of communication assets to extend its reach, strengthen stakeholder engagement, and increase understanding of sepsis.

Our client, a health insurance organisation, sought to improve profitability and redesign its service model while securing stakeholder buy-in and supporting implementation. We developed a tailored service-centre sizing model that accounted for interaction volumes, handling times, service levels, seasonal demand, channel mix, and varying agent skill levels. Where client data was incomplete, we incorporated relevant benchmarks and validated assumptions with internal experts. This enabled the client to determine the FTE requirements for each agency group, channel, and skill level, while providing a practical set of scenarios to close the gap between current performance and desired service levels.

The current Belgian healthcare system is facing significant challenges. Despite substantial public expenditure, questions have been raised about whether the achieved levels of quality justify the costs. The fragmented nature of healthcare financing and decision-making, further complicated by Belgium's multi-level governance system, aggravate these issues. To better understand the situation and potential solutions, our client commissioned us to answer three questions: (i) How sustainable is the current Belgian healthcare system and which challenges does it face? (ii) Can VBHC be a solution to tackle these challenges? and (iii) How can VBHC be implemented in Belgium to create a more sustainable healthcare system? A series of interactive workshops was held with relevant key stakeholders across all healthcare sectors and the outcome, including a joint vision and roadmap, was described in a whitepaper.

Our client, a global consumer healthcare company, needed to deliver ongoing cost savings while supporting growth across key markets. We conducted a detailed distribution network design exercise, modelling and evaluating future-state scenarios against agreed cost, service, and operational criteria, while taking into account relevant regulatory constraints. The preferred scenario consolidated the warehouse network from 24 to 15 distribution centres and identified annualised savings of 7%. We also completed a market-level cost-to-serve assessment, uncovering further savings opportunities of up to 15% in selected markets through changes to delivery frequency and shipment sizes.